Vestor Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-580
Closed -$41K 292
2026
Q1
$41K Sell
580
-2,165
-79% -$171K ﹤0.01% 275
2025
Q4
$48K Buy
2,745
+1,887
+220% +$147K ﹤0.01% 245
2025
Q3
$64K Sell
858
-901
-51% -$67.2K ﹤0.01% 239
2025
Q2
$628K Buy
1,759
+901
+105% +$62.7K 0.05% 98
2025
Q1
$69K Sell
858
-7
-0.8% -$602 0.01% 210
2024
Q4
$68K Buy
865
+7
+0.8% +$595 0.01% 225
2024
Q3
$81K Hold
858
0.01% 192
2024
Q2
$67K Hold
858
0.01% 204
2024
Q1
$78K Buy
858
+200
+30% +$16.6K 0.01% 198
2023
Q4
$51K Hold
658
﹤0.01% 219
2023
Q3
$45K Hold
658
﹤0.01% 232
2023
Q2
$53K Hold
658
0.01% 237
2023
Q1
$54K Buy
+658
New +$47K 0.01% 218

Other funds holding GEHC

Vestor Capital's GEHC Position: Q2 2026 in Review

Vestor Capital sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 580 shares — an estimated $41K sold.

Vestor Capital first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $628K in Q2 2025. 1,227 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Vestor Capital reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Vestor Capital sold 580 GE HealthCare shares in Q2 2026, an estimated $41K.
  • Vestor Capital first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Vestor Capital's GE HealthCare position peaked at $628K in Q2 2025.
  • 1,227 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.